New Alzheon Peer-Reviewed Scientific Publication Describes Study Design and Baseline Characteristics from APOLLOE4 Phase 3 Trial of Oral ALZ-801/Valiltramiprosate in APOE4/4 Homozygous ...

LIBerate-HoFH study was part of a global registration-enabling Phase 3 program of > 2,900 patients Biologics license application for lerodalcibep submitted to FDA in December 2024 CINCINNATI ...

TRANSCEND is a phase I, open-label, multicenter, multicohort, seamless design study evaluating the safety, antitumor activity, and cellular kinetics of liso-cel in adult patients with R/R B-cell ...